Dr. Thomas Herzog
Claim this profileUniversity of Cincinnati
Studies Ovarian Cancer
Studies Relapse
3 reported clinical trials
5 drugs studied
Area of expertise
1Ovarian Cancer
AKT positive
BRCA1 positive
PI3K positive
2Relapse
Affiliated Hospitals
More about Thomas Herzog
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Thomas Herzog has experience with
- Paclitaxel
- VB-111
- Afuresertib
- Alpelisib
- Olaparib
Breakdown of trials Thomas Herzog has run
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Herzog specialize in?
Thomas Herzog focuses on Ovarian Cancer and Relapse. In particular, much of their work with Ovarian Cancer has involved AKT positive patients, or patients who are BRCA1 positive.
Is Thomas Herzog currently recruiting for clinical trials?
No, Thomas Herzog is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Thomas Herzog has studied deeply?
Yes, Thomas Herzog has studied treatments such as Paclitaxel, VB-111, Afuresertib.
What is the best way to schedule an appointment with Thomas Herzog?
Apply for one of the trials that Thomas Herzog is conducting.
What is the office address of Thomas Herzog?
The office of Thomas Herzog is located at: University of Cincinnati, Cincinnati, Ohio 45267 United States. This is the address for their practice at the University of Cincinnati.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.